HRT and Bone Density: 137,484 Women Make the Case
You’ve been told hormones are risky. Protect your bones with calcium and vitamin D, they said. Your doctor handed you a DEXA scan result, sent you home with a prescription for a bisphosphonate, a drug with its own serious side effect profile, and the conversation about hormone therapy never happened. I’ve had this conversation with patients more times than I can count. And a study presented at the 2026 Annual Meeting of the American Academy of Orthopaedic Surgeons just made it harder to justify that silence.
In the largest real-world study ever conducted on HRT and bone density outcomes, researchers examined 137,484 postmenopausal women over five years. Women who started hormone therapy early, within one year of their menopause diagnosis, had an 18% lower risk of developing osteoporosis. And at maximum follow-up, they had a 13% lower fracture risk compared to women who never used HRT.
Those are not soft numbers. That is 137,484 women, carefully matched for demographics, bone-modifying medications, and metabolic conditions. And the data says: early hormone therapy protects your bones.
HRT and Bone Density: What 137,484 Women Show
The study, conducted by James Barsi, MD, and colleagues at Stony Brook University, used the TriNetX Research Network to identify 137,484 postmenopausal women under age 60 with a documented menopause diagnosis within the prior 20 years. Researchers divided participants 1:1 using propensity-score matching into two equal groups: those who started HRT within one year of menopause and those who never used it. Both groups had balanced baseline characteristics for demographics, nutritional deficiencies, metabolic conditions affecting bone health, and the use of bone-modifying agents. The team excluded women with prior HRT use, preexisting bone malformations, or previous fractures.
The findings across five years of follow-up were clear. The non-HRT group showed a significantly higher risk of developing osteoporosis compared to the HRT group (OR 1.18, 95% CI 1.092 to 1.284, p less than 0.0001). For fractures, the gap widened over time: no significant difference at three years, a 6% higher risk in the non-HRT group at five years (RR 1.06), and a 13% higher risk at maximum follow-up (RR 1.13).
Translation: the bone protection from early HRT accumulates over time. The longer the follow-up, the larger the gap between women who got early hormone support and those who did not.
Why Timing Matters for HRT and Bone Density
Bone remodeling is a continuous process: old bone breaks down and new bone forms to replace it. Estrogen regulates both sides of that equation. It slows the breakdown of old bone (resorption) and supports the formation of new bone. When estrogen drops at menopause, this balance tips sharply toward breakdown. Women lose 20% of their bone density in the five to seven years immediately following menopause. That loss is not gradual. It is rapid.
Starting HRT early, within the first one to two years of menopause, means you are supporting that process while the foundation is still being laid. Waiting until bone density is already significantly compromised is like trying to rebuild a house after the foundation has cracked.
The women who came to me 15 years ago, whose doctors told them to wait and handed them calcium with instructions to walk more, come back now with osteoporotic fractures and the quality-of-life consequences that follow. Hip fractures in postmenopausal women carry a one-year mortality rate of up to 20%. This is not a cosmetic concern. It is a survival concern.
What Early HRT Means in Real Terms
The AAOS study enrolled women under 60. This matters because it clarifies what “early” means in the context of bone protection. Women in their late 40s and early 50s initiating HRT promptly after their menopause diagnosis had measurably better bone outcomes five years later and beyond. That benefit held independent of calcium supplements and other bone medications, because researchers matched both groups for those factors.
At Living Well Dallas, bone health is part of every comprehensive hormone workup. A DEXA scan alone tells you what has already happened. What we want to know is why it’s happening and what we can do upstream: hormone levels, gut absorption of calcium, vitamin D and K2 status, cortisol’s impact on bone resorption, and whether HRT is an appropriate part of the plan.
A Complete Bone Health Evaluation Goes Beyond the DEXA
The conventional approach to bone health in postmenopausal women runs like this: DEXA scan, osteopenia or osteoporosis diagnosis, bisphosphonate prescription. Nobody asked about hormones. Vitamin K2 went unchecked. Nobody looked at gut health and whether calcium was actually absorbing. Cortisol, which actively breaks down bone when chronically elevated, never came up either.
That is not a root-cause evaluation. That is a symptom-level prescription.
A complete workup for a postmenopausal woman worried about her bones includes hormone levels (estrogen, progesterone, testosterone, DHEA), vitamin D and K2 status, cortisol pattern across the day, gut absorption markers, and an honest conversation about HRT candidacy based on her full clinical picture.
The AAOS data gives us a concrete reason to have that HRT conversation earlier. Not after the fracture. Not after the T-score has crossed into osteoporosis. During perimenopause, when the protective option is still at its most effective. Menrva Health offers full bone and hormone assessments through telehealth in all 50 states.
Key Takeaways
- The largest real-world study ever on HRT and bone density: 137,484 matched postmenopausal women, five-year follow-up.
- Women who started HRT within one year of menopause had an 18% lower risk of developing osteoporosis (OR 1.18).
- Fracture risk was 13% lower in the early-HRT group at maximum follow-up (RR 1.13), with the gap widening over time.
- Women lose up to 20% of bone density in the five to seven years immediately after menopause; estrogen is the primary regulator of that loss.
- A complete bone health evaluation includes hormones, vitamin D and K2, cortisol, and gut absorption, not just a DEXA result.
Frequently Asked Questions
Does HRT actually prevent osteoporosis or just slow it down? Both, and the distinction matters. Estrogen reduces the rate of bone resorption (breakdown) and supports bone formation. In this study of 137,484 women, those who started HRT early had an 18% lower rate of an osteoporosis diagnosis over five years compared to women who never used HRT. That is a meaningful reduction, not just a delay. The sooner HRT is started after menopause, the more of that rapid post-menopausal bone loss is prevented.
What if my doctor says HRT is too risky for me? The risk-benefit calculation for HRT depends on many individual factors: personal and family history, age, time since menopause, cardiovascular risk, and formulation. Blanket refusals based on outdated WHI data are not evidence-based medicine. Ask your doctor specifically which risk they are concerned about, and whether a transdermal formulation with natural progesterone has been considered. If the conversation stops there, find a physician who will have it.
Getting the Most from Your HRT and Bone Density Plan
Should I stop my bisphosphonate if I start HRT? This is a clinical conversation that depends on your DEXA results, how long you’ve been on the bisphosphonate, and your overall health picture. Both can be used together in some cases. What I generally want to see is whether the root cause of the bone loss is being addressed, not just whether a medication is suppressing the symptom of it. HRT addresses a primary driver. Bisphosphonates treat the downstream effect.
What role does diet play alongside HRT for bone health? Diet is essential and does not get enough attention in the bone health conversation. Calcium is the raw material, but without adequate vitamin D for absorption, vitamin K2 to direct calcium into bone rather than arteries, and adequate protein for bone matrix support, the building blocks are not getting to where they need to go. Additionally, high-glycemic diets and chronically elevated cortisol both accelerate bone resorption. Diet is not a replacement for HRT in women who need it, but it determines how well the whole system works.
Understanding Your Full Bone Health Picture
Is a DEXA scan enough to understand my bone health risk? No, and this is a significant gap in standard care. A DEXA scan tells you your bone density right now. It does not tell you your rate of loss, what is driving the loss, or whether your lifestyle and hormonal picture give you any protection going forward. A functional workup adds hormone levels, vitamin D and K2, cortisol, gut markers, and often a biomarker of bone turnover like serum CTX, which tells you how fast bone is currently breaking down.
What is the right age to start thinking about bone health and HRT? The right time is perimenopause, not after a fracture. This study enrolled women under 60, and the bone protection effect was clear and measurable. The earlier the conversation starts, the more rapid post-menopausal bone loss you can prevent. Waiting until a DEXA shows osteopenia or osteoporosis is waiting for the damage to have already been done.
Dr. Betty’s Bottom Line
For years, I have watched women lose bone density that early hormone support could have preserved. The system gave them calcium. It gave them bisphosphonates. It handed them a DEXA result and scheduled a follow-up in two years. What it did not do was have the hormone conversation early, when it would have mattered most.
This study of 137,484 women is not a small trial. It is a real-world dataset, propensity-matched, followed for five years. And it says that women who started hormone therapy early had 18% lower osteoporosis risk and 13% lower fracture risk. Those numbers represent real women who did not fracture. Women who never spent weeks recovering from a hip surgery. Women who kept their quality of life and independence intact.
The bone health conversation needs to start in perimenopause. Not at the first fracture. Hormone therapy, where it is clinically appropriate, is one of the most effective tools we have for keeping women standing, active, and structurally intact into their 60s and beyond.
In-person care at Living Well Dallas is available for patients in the Dallas area. Menrva Health provides comprehensive bone, hormone, and metabolic assessments through telehealth in all 50 states. If your doctor has not discussed HRT and bone density with you, that conversation is overdue.
Source: Barsi JD, et al. Early Hormone Replacement Therapy and Long-Term Bone Health in Postmenopausal Women: A Real-World Propensity-Matched Study. Presented at AAOS 2026 Annual Meeting, New Orleans. March 2, 2026.